New Delhi: The patent battle between US pharmaceuticals major Merck Sharp and Dohme (MSD) and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday. Indian pharma company Glenmark recently came out with generic versions of Merck's type-2 diabetes drugs at a 30 per cent lower price, in alleged violation of Merck's intellectual property rights.
Merck had introduced its drugs in India in 2008, pegged at one-fifth the United States price. According to market sources, a strip of seven tablets of Januvia (50 mg and 100 mg) is priced at Rs 300 while Glenmark's version costs around 30 per cent less.
MSD, in its plea, had alleged that the Indian pharma company has violated its intellectual property right (IPR) over its anti-diabetes medicines, Januvia and Janumet, by coming in the market with their own drugs containing the same salts.
(With Additional Information From PTI)...
more
10:15 AM, May 23, 2013
Pawan Kumar Bansal is under fire over bribery charges against his nephew Vijay Singhla, who is also one of the directors of Jagan Realtors Private Limited, which has several other relatives of Bansal on board. ...
10:12 PM, May 07, 2013
The BJP has now claimed Theon Pharmaceuticals was involved in price fixing. Pawan Kumar Bansal's wife Madhu Bansal, sons Manish Bansal and Amit Bansal are directors in Theon Pharmaceuticals. ...
07:13 PM, May 07, 2013
New York: The US government has sued Novartis Pharmaceuticals Corp, claiming it gave kickbacks to pharmacies to switch kidney transplant patients from competitors' drugs to its own. The civil health care fraud lawsuit in US District Court in Manhattan seeks unspecified damages and civil penalties for a scheme that the government said has been carried out since 2005. US Attorney Preet Bharara said on Tuesday that the company used the...
09:00 AM, Apr 24, 2013
Dhoni, has been signed as the brand ambassador of Emcure Pharmaceuticals, a company that specialises in tablets, capsules, injectables and Onco products. ...
11:48 PM, Mar 12, 2013
The US arm of Indian drug major Ranbaxy Laboratories has entered into an in-licensing agreement with Alembic Pharmaceuticals Limited to exclusively market the generic version of Pfizer Inc.'s anti-depression drug Pristiq in the US. ...
01:55 PM, Mar 06, 2013
Prisoners in Ananthapur in Andhra Pradesh are getting a second chance in life. Through a unique rehabilitation program started by the pharmaceutical company Himalaya, the inmates are now turning to herb farming. ...
10:20 AM, Feb 19, 2013
Bangalore: Drug-maker Cipla on Thursday said it has appointed Subhanu Saxena as the Chief Executive Officer of the company. The appointment is effective from February 1, 2013. Saxena has more than 25 years of work experience. He has worked with companies such as Citicorp, The Boston Consulting Group and PepsiCo, across markets in Europe, North America, Africa and Asia, Cipla said in a statement. In his last assignment, Saxena led...
09:16 AM, Nov 22, 2012
New Delhi: Ranbaxy Laboratories on Friday said it has launched generic pioglitazone hydrochloride tablets used for treating diabetes in the American market under an agreement with Takeda Pharmaceuticals USA Inc. The company's wholly-owned subsidiary Ranbaxy Pharmaceuticals Inc has launched the drug following the expiry of patent held by Takeda Pharmaceutical. Ranbaxy is among the three companies, including Teva and Mylan, to have 180-days of marketing exclusivity for the drug in...
05:34 PM, Aug 17, 2012
Washington: GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in US history. The agreement, which still needs court approval, would resolve allegations that the British drugmaker broke US laws in the marketing and development of pharmaceuticals. GSK targeted the antidepressant Paxil to patients under age 18 when it was...
09:54 AM, Jul 03, 2012
New Delhi: India and Brazil have agreed to set up six working groups in sectors like agro-processing, mining, infrastructure and pharmaceuticals aimed at increasing collaboration in these areas and strengthen economic ties. "Our governments have agreed to set up six working groups on agro processing, services and IT, mining, infrastructure, engineering and pharmaceuticals," Commerce and Industry Minister Anand Sharma said. He was speaking at the Brazil-India Business Session jointly organised...
04:51 AM, Mar 31, 2012
Mumbai: Swiss drugmaker Roche Holding plans to offer cut-price versions of two blockbuster cancer drugs for the Indian market soon, a company spokesman said on Friday, days after the government moved to slash the price of another cancer treatment. India stripped German group Bayer of exclusive rights to Nexavar earlier this month and licenced a local company to produce a cheap, generic version, on the grounds that poor Indians could...
02:39 AM, Mar 24, 2012
Mumbai: Two Anil Ambani group firms, Reliance Communications and Reliance Infrastructure, will move out of Bombay Stock Exchange's blue chip index Sensex in August. While RCom would be replaced by Sun Pharmaceuticals, RInfra would be substituted by Coal India on the 30-share index. The changes would be effective from August 8, Bombay Stock Exchange (BSE) said in a statement on Friday. Coal India shares have been doing well since the...
10:05 PM, Jun 17, 2011
Boston: Regeneron Pharmaceuticals Inc said on Monday that US regulators placed the company's experimental pain drug for osteoarthritis on clinical hold after a patient in another company's trial developed a serious bone disorder. Regeneron said it and its partner, Sanofi-Aventis SA, were informed late last week by the US Food and Drug Administration that the drug, REGN475/SAR164877, was being placed on clinical hold after a patient in another company's trial...
09:53 AM, Dec 28, 2010
Cervical cancer claims 74,000 lives every year in India. Now a new vaccine claims to prevent the disease. ...
02:29 PM, Apr 16, 2010
The deal is believed to be more that Rs 5 crore annually. ...
03:48 PM, Jan 07, 2010
Pharma major's owner Desh Bandhu Gupta poised for big things. ...
05:01 PM, Dec 02, 2009
Cadila will file an application for clinical trials of the vaccine in the next two days. ...
09:35 AM, Aug 17, 2009
33 drugs seized from facility; company's shares fall in BSE. ...
02:38 PM, Jun 26, 2009
Company says it will respond to American regulator's letter. ...
11:32 AM, Feb 26, 2009
